A previous report showed that the expression of ICOS on the surface of CD4+ T cells and soluble ICOS in the peripheral blood of patients with systemic sclerosis [39] and systemic lupus erythematosus [40] are significantly increased. This evidence concerns the gene ICOS and systemic lupus erythematosus.